{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:16:11Z","timestamp":1793103371564,"version":"4.5.0"},"reference-count":112,"publisher":"American Society for Clinical Investigation","issue":"12","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,22]]},"abstract":"<jats:p>p38 MAPKs play a central role in orchestrating the cellular response to stress and inflammation and in the regulation of myogenesis. Potent inhibitors of p38 MAPKs have been pursued as potential therapies for several disease indications due to their antiinflammatory properties, although none have been approved to date. Here, we provide a brief overview of p38 MAPKs, including their role in regulating myogenesis and their association with disease progression. Finally, we discuss targeting p38 MAPKs as a therapeutic approach for treating facioscapulohumeral muscular dystrophy and other muscular dystrophies by addressing multiple pathological mechanisms in skeletal muscle.<\/jats:p>","DOI":"10.1172\/jci.insight.149915","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T14:01:31Z","timestamp":1624284091000},"source":"Crossref","is-referenced-by-count":94,"title":["p38 MAPKs \u2014 roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets"],"prefix":"10.1172","volume":"6","author":[{"given":"Christopher M.","family":"Brennan","sequence":"first","affiliation":[{"name":"Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles P.","family":"Emerson","sequence":"additional","affiliation":[{"name":"Wellstone Muscular Dystrophy Program, Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-7202","authenticated-orcid":true,"given":"Jane","family":"Owens","sequence":"additional","affiliation":[{"name":"Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-6919","authenticated-orcid":true,"given":"Nicolas","family":"Christoforou","sequence":"additional","affiliation":[{"name":"Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"11","key":"B1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011254","article-title":"MAP kinase pathways","volume":"4","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(00)01595-4"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20100323"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2015.0032"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2327"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00525-7"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.12.013"},{"issue":"4","key":"B8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cellsig.2005.05.013","article-title":"Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli","volume":"18","author":"Zhuang","year":"2006","journal-title":"Cell Signal"},{"issue":"4","key":"B9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nsb0497-311","article-title":"A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket","volume":"4","author":"Tong","year":"1997","journal-title":"Nat Struct Biol"},{"issue":"30","key":"B10","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1074\/jbc.271.30.17920","article-title":"Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"},{"issue":"7","key":"B11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0192-0561(88)90007-0","article-title":"Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&amp;F 86002","volume":"10","author":"Lee","year":"1988","journal-title":"Int J Immunopharmacol"},{"issue":"6508","key":"B12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"issue":"2\u20133","key":"B13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0162-3109(00)00206-X","article-title":"Inhibition of p38 MAP kinase as a therapeutic strategy","volume":"47","author":"Lee","year":"2000","journal-title":"Immunopharmacology"},{"issue":"3","key":"B14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/13543784.2015.1006358","article-title":"Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease","volume":"24","author":"Norman","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2016.00091","article-title":"Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway","volume":"4","author":"Segal\u00e9s","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"B16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tcb.2005.11.002","article-title":"Regulation of skeletal muscle gene expression by p38 MAP kinases","volume":"16","author":"Llu\u00eds","year":"2006","journal-title":"Trends Cell Biol"},{"issue":"4-5","key":"B17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semcdb.2005.07.006","article-title":"MyoD and the transcriptional control of myogenesis","volume":"16","author":"Berkes","year":"2005","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"B18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z","article-title":"Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications","volume":"185","author":"Puri","year":"2000","journal-title":"J Cell Physiol"},{"issue":"3","key":"B19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.devcel.2015.10.019","article-title":"E proteins and ID proteins: helix-loop-helix partners in development and disease","volume":"35","author":"Wang","year":"2015","journal-title":"Dev Cell"},{"issue":"3","key":"B20","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.18632\/oncotarget.6223","article-title":"MEF2 transcription factors: developmental regulators and emerging cancer genes","volume":"7","author":"Pon","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"B21","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1074\/jbc.274.7.4341","article-title":"Stress-activated protein kinase-2\/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis","volume":"274","author":"Cuenda","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"B22","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1074\/jbc.274.8.5193","article-title":"p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor","volume":"274","author":"Zetser","year":"1999","journal-title":"J Biol Chem"},{"issue":"11","key":"B23","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1128\/MCB.20.11.3951-3964.2000","article-title":"p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps","volume":"20","author":"Wu","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"6622","key":"B24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/386296a0","article-title":"Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation","volume":"386","author":"Han","year":"1997","journal-title":"Nature"},{"issue":"1","key":"B25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/MCB.19.1.21","article-title":"Regulation of the MEF2 family of transcription factors by p38","volume":"19","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"5","key":"B26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.emboj.7600528","article-title":"E47 phosphorylation by p38 MAPK promotes MyoD\/E47 association and muscle-specific gene transcription","volume":"24","author":"Llu\u00eds","year":"2005","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjs045"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ng1378"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312288200"},{"issue":"1","key":"B30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13395-016-0074-x","article-title":"Chromatin-wide and transcriptome profiling integration uncovers p38\u03b1 MAPK as a global regulator of skeletal muscle differentiation","volume":"6","author":"Segal\u00e9s","year":"2016","journal-title":"Skelet Muscle"},{"issue":"6","key":"B31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.molcel.2005.10.021","article-title":"p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts","volume":"20","author":"Briata","year":"2005","journal-title":"Mol Cell"},{"issue":"5","key":"B32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.emboj.7601587","article-title":"Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation","volume":"26","author":"Perdiguero","year":"2007","journal-title":"EMBO J"},{"issue":"1","key":"B33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol Rev"},{"key":"B34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2015.09.017","article-title":"PAX3 and PAX7 as upstream regulators of myogenesis","volume":"44","author":"Buckingham","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"B35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/dbio.1999.9565","article-title":"A new look at the origin, function, and \u201cstem-cell\u201d status of muscle satellite cells","volume":"218","author":"Seale","year":"2000","journal-title":"Dev Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001930106"},{"issue":"2","key":"B37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1006\/dbio.1994.1226","article-title":"Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers","volume":"164","author":"Yablonka-Reuveni","year":"1994","journal-title":"Dev Biol"},{"issue":"Pt 17","key":"B38","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1242\/jcs.112.17.2895","article-title":"In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle","volume":"112","author":"Cooper","year":"1999","journal-title":"J Cell Sci"},{"issue":"5","key":"B39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2007.03.044","article-title":"Asymmetric self-renewal and commitment of satellite stem cells in muscle","volume":"129","author":"Kuang","year":"2007","journal-title":"Cell"},{"issue":"3","key":"B40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1083\/jcb.200312007","article-title":"Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?","volume":"166","author":"Zammit","year":"2004","journal-title":"J Cell Biol"},{"issue":"1","key":"B41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1083\/jcb.200408066","article-title":"The p38alpha\/beta MAPK functions as a molecular switch to activate the quiescent satellite cell","volume":"169","author":"Jones","year":"2005","journal-title":"J Cell Biol"},{"issue":"4","key":"B42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2010.08.013","article-title":"TNF\/p38\u03b1\/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration","volume":"7","author":"Palacios","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"4","key":"B43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stem.2012.05.025","article-title":"Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38\u03b1\/\u03b2 MAPK","volume":"11","author":"Troy","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200907037"},{"issue":"8","key":"B45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.51.34391"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/352371","article-title":"Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses","volume":"2014","author":"Yang","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100685200"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/art.24266"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100602"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000122"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.05.024"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/art.24264"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70200-5"},{"issue":"3","key":"B55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194197","article-title":"The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: a randomised double-blind placebo-controlled trial","volume":"13","author":"Fisk","year":"2018","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa7322"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.03.015"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182518302"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199610)19:10<1291::AID-MUS6>3.0.CO;2-9"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000148485.00049.B7"},{"issue":"3","key":"B61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbadis.2004.12.003","article-title":"Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise","volume":"1740","author":"Nakamura","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-150045"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23312"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu270"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912023412302"},{"issue":"4","key":"B66","first-page":"309","article-title":"Dilated cardiomyopathy produced by lamin A\/C gene mutations","volume":"86","author":"Goidescu","year":"2013","journal-title":"Clujul Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds265"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy040"},{"issue":"Pt 3","key":"B69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1242\/jcs.110.3.357","article-title":"Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27","volume":"110","author":"Guay","year":"1997","journal-title":"J Cell Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290105"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.092022999"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/6799"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.5.473"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.9.1453"},{"issue":"4","key":"B75","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/j.2040-4603.2017.tb00779.x","article-title":"Facioscapulohumeral muscular dystrophy","volume":"7","author":"DeSimone","year":"2017","journal-title":"Compr Physiol"},{"issue":"6","key":"B76","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/CON.0000000000000801","article-title":"Facioscapulohumeral muscular dystrophies","volume":"25","author":"Wagner","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.5.951"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21091"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ng999"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001181"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209508109"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2011.11.013"},{"issue":"20","key":"B83","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","article-title":"Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways","volume":"24","author":"Rickard","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"20","key":"B84","first-page":"4419","article-title":"Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells","volume":"25","author":"Jagannathan","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146893"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg327"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.08.007"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.06.041"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.158"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006658"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.201"},{"issue":"3","key":"B92","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22275","article-title":"DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo","volume":"69","author":"Wallace","year":"2010","journal-title":"Ann Neurol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.04.002"},{"issue":"21","key":"B94","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1242\/jcs.205427","article-title":"The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain","volume":"130","author":"Bosnakovski","year":"2017","journal-title":"J Cell Sci"},{"issue":"6","key":"B95","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/CON.0000000000000399","article-title":"Facioscapulohumeral muscular dystrophy","volume":"22","author":"Statland","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy364"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.264689"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.259663"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay0271"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.33.23570"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0953-03"},{"key":"B102","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12010","article-title":"The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons","volume":"5","author":"Park","year":"2016","journal-title":"Elife"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2014.6090"},{"issue":"2","key":"B104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/cc.10.2.14441","article-title":"Selective control of Pax7 expression by TNF-activated p38\u03b1\/polycomb repressive complex 2 (PRC2) signaling during muscle satellite cell differentiation","volume":"10","author":"Mozzetta","year":"2011","journal-title":"Cell Cycle"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa164"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu251"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0472-9"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.23.6845"},{"issue":"9","key":"B109","first-page":"2464","article-title":"A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents","volume":"60","author":"Sanchez-Prieto","year":"2000","journal-title":"Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041502"},{"key":"B111","unstructured":"Fulcrum Therapeutics. Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD. https:\/\/ir.fulcrumtx.com\/node\/6656\/pdf Updated October 4, 2019. Accessed February 16, 2021"},{"key":"B112","unstructured":"Fulcrum Therapeutics. Fulcrum Therapeutics Announces Interim Analysis Data from its ReDUX4 Trial in Facioscapulohumeral Muscular Dystrophy (FSHD). https:\/\/ir.fulcrumtx.com\/node\/7386\/pdf Updated August 11, 2020. Accessed February 16, 2021."}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/149915\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:47:35Z","timestamp":1779148055000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/149915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":112,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6,22]]},"published-print":{"date-parts":[[2021,6,22]]}},"alternative-id":["10.1172\/jci.insight.149915"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.149915","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"article-number":"e149915"}}